
        <!DOCTYPE html>
        <html>
        <head>
            <title>Biogen Inc. (BIIB) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Biogen Inc. (BIIB)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">‚Üê Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">30</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">14</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">8</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.08</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9f44526e9dc0c3ba2c7e7c2d14ca08ae9c92b6ace1a1888bdd61cc6d8e9b694c" target="_blank" rel="noopener noreferrer">Biogen Inc. stock outperforms competitors on strong trading day</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-06</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock outperforms competitors on strong trading day...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=27c25d966e811b2ffc37491bf3e1b81d584ef4da3f56dbf2b62bc8de1c94d7f1" target="_blank" rel="noopener noreferrer">Why Is Krystal Biotech (KRYS) Down 3.5% Since Last Earnings Report?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-05</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.39
                                </span>
                            </div>
                            <div class="article-summary">Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0f37203c785ec6e1cccb618e1a08abff500501d39b425a8bba3ca62b928dd14b" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Thursday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-05</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Thursday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=38a3fa6a8cead9c9e75f77bfc020116de74993e8dc05a0e0b75137cad50c9df0" target="_blank" rel="noopener noreferrer">abrdn World Healthcare Fund Q1 2025 Commentary</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-03</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">The equity portion of the Fund rose (gross of fees) but underperformed its benchmark over the quarter....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ffbbd1d9d0ee42f7282b6240d93b09824516bf8fc1547da4f1cdfa8aeebce746" target="_blank" rel="noopener noreferrer">Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.36
                                </span>
                            </div>
                            <div class="article-summary">Maha Radhakrishnan, MD Maha Radhakrishnan, MD BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the appointment of Maha Radhakrishnan, M.D., to its Bo...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8f277ff4a23eb1a9d0a073121fe3f8808f7909282b7e596f16af16b15f12e51c" target="_blank" rel="noopener noreferrer">Biogen : to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-03</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Cambridge, MA, - - Biogen Inc. announced today that Robin Kramer, Chief Financial Officer, will participate in a fireside chat during the Goldman Sachs 46th Annual Global Healthcare Conference. The......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e17dcc444ba7286ea5d30c896b29e0cf8eb2249f5a104b4b378012088b5ef637" target="_blank" rel="noopener noreferrer">Biogen Files Suit Against Neurimmune Over Rights To Bispecific Antibody</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-02</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.68
                                </span>
                            </div>
                            <div class="article-summary">On May 13, 2025, Biogen Inc. and Biogen MA Inc. filed a Complaint for Declaratory Judgment and Permanent Injunctive Relief against Neurimmune Holding AG and Neurimmune SubOne AG in the U.S. District.....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6a43801cb46ae43d45b78fba22426c61b25efdf36ba75aa6357f4220e9041fb1" target="_blank" rel="noopener noreferrer">abrdn Life Sciences Investors Q1 2025 Commentary</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-31</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5e602a9d616ac83a6a50a36419ece3ad23b7b2a464982b92055c69e8d8bb99b2" target="_blank" rel="noopener noreferrer">Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.38
                                </span>
                            </div>
                            <div class="article-summary">The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let‚Äôs take a look at how therapeutics stocks fared in Q1, starting with Biogen (NASDA...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6c11d2e8500b3b8d4b63336f19c7b6ddca285808a1a42a771ca6a9c173168ad7" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Friday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-30</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Friday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1e7d92db3a9a6deb916832c5a4b060682f0d92a3ed0504842b833e4bd3cc2df2" target="_blank" rel="noopener noreferrer">Biogen Inc. (BIIB) Taps RNAi Therapy in City Therapeutics Deal</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. (NASDAQ:BIIB)‚Äôs recent partnership with City Therapeutics, Inc. to develop RNAi therapies for central nervous system diseases has fueled a 6% rise in its share price over the past month, r...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6c68e5c45080a99900b4d143e8b1dda69a1509d110140e403aa928ad9e819def" target="_blank" rel="noopener noreferrer">Biogen and City Therapeutics to develop RNAi therapy</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biogen will pay City Therapeutics $46m, which includes $16m upfront and $30m investment for a convertible note....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=04774730757f1fa40e6bfb98d905333f1c463c975d55eb867abca3d03244ac7e" target="_blank" rel="noopener noreferrer">Biogen to Pay $46M in RNAi-Development Collaboration</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biogen to Pay $46M in RNAi-Development Collaboration...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f07b8686f8311dee720d196e8677ec9f7315db42f5258960e4751dbdcc79e679" target="_blank" rel="noopener noreferrer">Biogen Inc. and City Therapeutics, Inc. Announce Strategic Research Collaboration to Develop Select Novel Rnai-Based Therapies</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.86
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. and City Therapeutics, Inc. announced a strategic collaboration to develop select novel RNAi therapies. Through the collaboration, City Therapeutics will leverage its next-generation RNAi....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=03dca823c5463f9f58641193c57453a1944a42631a20b86d87eb10705cd334d5" target="_blank" rel="noopener noreferrer">Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.81
                                </span>
                            </div>
                            <div class="article-summary">Collaboration leverages City Therapeutics‚Äô next-generation RNAi engineering technologies and Biogen‚Äôs extensive drug development expertiseCAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Biogen Inc....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cd21c55484ebafe468cda9858349ebebfc8492481f352b5cad67683d3ec7b474" target="_blank" rel="noopener noreferrer">Biogen strikes RNAi deal with City; Aurion withdraws IPO</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.37
                                </span>
                            </div>
                            <div class="article-summary">City will receive $46 million from Biogen under the alliance. Elsewhere, Angelini Pharma licensed a rare disease therapy and the FDA refused to review a Savara lung drug....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3a516df6f6a2f4bdd4b6a35401ade22a30a38181e992382a0234a75784023aab" target="_blank" rel="noopener noreferrer">Biogen (NasdaqGS:BIIB) Partners With City Therapeutics in US$1 Billion RNAi Therapy Deal</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.86
                                </span>
                            </div>
                            <div class="article-summary">Biogen (NasdaqGS:BIIB) recently announced a collaboration with City Therapeutics, Inc. to develop RNAi therapies for central nervous system diseases, contributing to a 6% share price increase over the...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6c1d3a2de611d9c2ea55a93a5a3c840711fc613f97468a465036b839226e8ac0" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Wednesday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-21</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.91
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Wednesday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e392379a44ca24fa9fbbae43851bd5d30f9417655b0ea5ecd832639cc3ff2154" target="_blank" rel="noopener noreferrer">FDA approves first blood test for detecting Alzheimer's</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-19</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.68
                                </span>
                            </div>
                            <div class="article-summary">The US Food and Drug Administration has approved the first blood test that can help detect Alzheimer's disease. The approval is for a test developed by Japanese company Fujirebio Diagnostics, which......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=af7b4ac376a0551b0c0aba5809132a2be839249f2a14ef493551e96d6b55090c" target="_blank" rel="noopener noreferrer">US FDA clears first blood test to detect Alzheimer's disease</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-16</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.74
                                </span>
                            </div>
                            <div class="article-summary">The U.S. Food and Drug Administrationsaid on Friday it had cleared Fujirebio Diagnostics' blood testto diagnose Alzheimer's disease, making the test the first ofits kind to detect the condition. ......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0731edc3f9898c6a5ae97f0598f5c716331eb14da220c5332607aa79f1a5711b" target="_blank" rel="noopener noreferrer">US FDA clears first blood test for Alzheimer's detection</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-16</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.33
                                </span>
                            </div>
                            <div class="article-summary">The U.S. Food and Drug Administrationhas cleared Fujirebio Diagnostics' blood test to diagnoseAlzheimer's disease, the regulator said on Friday, making thedevice the first of its kind to detect the......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=45495cdaf5c7dee7c96664176ebc3fb03fe8f183ee8c69c321869c93b4170d81" target="_blank" rel="noopener noreferrer">BIIB Q1 Earnings Call: New Product Growth Outpaces Declining MS Franchise Amid Lowered Guidance</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-15</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">Biotech company Biogen (NASDAQ:BIIB) beat Wall Street‚Äôs revenue expectations in Q1 CY2025, with sales up 6.1% year on year to $2.43 billion. Its non-GAAP profit of $3.02 per share was 1.9% above analy...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b756f83ede5a952ac1cd88a2f2bfbfaeb147a2d8042368572bb7e00b02603f9d" target="_blank" rel="noopener noreferrer">INmune Bio: XPro Trial Readout In Alzheimer's Disease Offers Big Opportunity</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-15</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.30
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=642997139796d1ec22e42b910d04d46a39c8d9d41e0d602b85609a2eb28d3a9d" target="_blank" rel="noopener noreferrer">Does Anavex's Alzheimer's Drug Actually Confer Benefit?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-15</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=210323bbad2fd90f6a3b34a2b755163066839f86f14a49779e0b101157935b42" target="_blank" rel="noopener noreferrer">3 Cash-Producing Stocks Skating on Thin Ice</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.94
                                </span>
                            </div>
                            <div class="article-summary">While strong cash flow is a key indicator of stability, it doesn‚Äôt always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competit...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1272b46f7fe159dc7039ced1fa299cd0801107db33b8267961fd3c174c7d69f7" target="_blank" rel="noopener noreferrer">Why Biogen Inc. (BIIB) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.21
                                </span>
                            </div>
                            <div class="article-summary">We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against othe...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57" target="_blank" rel="noopener noreferrer">Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-12</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=de61bb0fd808c39eb4637ed4d6bcb158d985380292e87942d3788c366eecff75" target="_blank" rel="noopener noreferrer">Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.42
                                </span>
                            </div>
                            <div class="article-summary">A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agre...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ae5be304ac20360b5fb2a0b392da7c0bb53e5121f216277048823a5dc24c803a" target="_blank" rel="noopener noreferrer">Q1 2025 Royalty Pharma PLC Earnings Call</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-09</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Q1 2025 Royalty Pharma PLC Earnings Call...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c839c0ccb4be48012897fc8ea8c1e692a2b6eaaeb3bffa442c92a5f66465d8e2" target="_blank" rel="noopener noreferrer">Therapeutics Stocks Q1 Results: Benchmarking Sarepta Therapeutics (NASDAQ:SRPT)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let‚Äôs take a look at how therapeutics stocks fared in Q1, starting with Sarepta Thera...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        